BRIEF published on 11/19/2025 at 23:05, 4 months 18 days ago Les résultats financiers de Medicure pour le troisième trimestre 2025 reflètent une croissance du chiffre d'affaires malgré une perte nette. Marley Drug Croissance Des Revenus Perte Nette Ventes D'AGGRASTAT® Résultats Financiers De Mediure
BRIEF published on 11/19/2025 at 23:05, 4 months 18 days ago Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE published on 11/19/2025 at 23:00, 4 months 18 days ago Medicure Reports Financial Results for Quarter Ended September 30, 2025 Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF published on 11/13/2025 at 23:35, 4 months 24 days ago Medicure annoncera ses résultats financiers du troisième trimestre 2025 le 20 novembre Résultats Financiers Medicure Inc. Conférence Téléphonique Produits Pharmaceutiques Américains AGGRASTAT® Et ZYPITAMAG®
BRIEF published on 11/13/2025 at 23:35, 4 months 24 days ago Medicure to Announce Q3 2025 Financial Results on November 20 Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE published on 11/13/2025 at 23:30, 4 months 24 days ago Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025 Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 08/20/2025 at 23:35, 7 months 18 days ago Medicure publie ses résultats financiers du deuxième trimestre 2025 Résultats Financiers Perte Nette Revenu Net Investissement Dans La Recherche Entreprise Pharmaceutique
BRIEF published on 08/20/2025 at 23:35, 7 months 18 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 7 months 18 days ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 7 months 20 days ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
Published on 04/08/2026 at 14:00, 19 minutes ago Horizon Aircraft and MHIRJ Join Forces to Advance Regional Air Mobility
Published on 04/08/2026 at 13:00, 1 hour 19 minutes ago Gold Terra Announces Assay Results of 22.46 g/t Gold over 5.2 Metres in the Walsh Lake Area, Northbelt, NWT
Published on 04/08/2026 at 13:00, 1 hour 19 minutes ago NuRAN Wireless Announces Private Placement and Provides Corporate Updates
Published on 04/08/2026 at 13:00, 1 hour 19 minutes ago Kalo Gold Confirms Vertically Continuous Gold System at Qiriyaga Complex and Identifies Untested Epithermal Feeder Target at Depth - 16.90 m at 3.25 g/t Au
Published on 04/08/2026 at 13:00, 1 hour 19 minutes ago Temas Expands Scientific Advisory Board with Appointment of Chemical Process Development Expert, Dr. Santiago Faucher
Published on 04/08/2026 at 14:05, 14 minutes ago Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
Published on 04/08/2026 at 14:05, 14 minutes ago Duck Creek Launches Duck Creek Reinsurance with Active Delivery to Help Insurers Simplify Program Management and Improve Financial Control
Published on 04/08/2026 at 14:05, 14 minutes ago H55 Delivers First Commercial, Certifiable Propulsion Battery Modules to BRM Aero for the Bristell B23 Energic Program
Published on 04/08/2026 at 14:05, 14 minutes ago Treon Secures €6.8 Million Investment Led by ACME Capital to Accelerate Industrial AI Innovation
Published on 04/08/2026 at 12:58, 1 hour 20 minutes ago EURAZEO SE VOIT ATTRIBUER LA NOTE DE CREDIT BBB (PERSPECTIVE STABLE) PAR S&P ET BBB (PERSPECTIVE STABLE) PAR FITCH.
Published on 04/08/2026 at 12:58, 1 hour 20 minutes ago EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH
Published on 04/08/2026 at 11:50, 2 hours 29 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025, incluant le rapport financier annuel 2025
Published on 04/08/2026 at 11:00, 3 hours 19 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 04/08/2026 at 11:00, 3 hours 19 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
